Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC67903 RIDR-PI-103 RIDR-PI-103 是一种活性氧 (ROS) 诱导的药物释放前药,具有与泛 PI3K 抑制剂 (PI-103) 连接的自环化部分。Doxorubicin 和 RIDR-PI-103 在 MDA-MB-361 和 MDA-MB-231 细胞中显示出抑制癌细胞增殖的协同作用。
  3. GC67892 CHD-5 CHD-5 是一种有效的 AhR (芳香烃受体)拮抗剂。
  4. GC67890 PHA 408 PHA 408 (PHA-408) 是一种有效的、选择性的、具有口服活性的 IκB kinase-2 (IKK-2) 抑制剂。PHA 408 是一种抗脂多糖 (LPS) 和香烟烟雾 (CS) 介导的肺炎症的强效抗炎药。
  5. GC67859 Clerodendrin Clerodendrin 是一种可从 Lobelia chinensis 中分离得到的天然产物。Clerodendrin 是一种有效的双重白介素-4 (IL-4) 抑制剂和 β-己糖氨基苷酶 (Hex) 抑制剂。
  6. GC67792 NSC49652 NSC49652 是一种可逆的、具有口服活性的 p75 neurotrophin receptor (p75NTR,也被称为 NGFR、TNFRSF16 和 CD271) 抑制剂。 NSC49652 作用于 p75NTR 的跨膜结构域。 NSC49652 诱导凋亡(Apoptosis),影响黑色素瘤细胞活力。
  7. GC67748 Brodalumab Brodalumab (AMG 827) 是一种抗人白介素 17 受体 (IL-17R) IgG2 单克隆抗体,可用于研究中重度斑块性银屑病和类风湿性关节炎。
  8. GC67721 CP-447697 CP-447697 是亲脂性的 C5a 受体拮抗剂,IC50 值为 31 nM。CP-447697 可用于炎症的研究。
  9. GC67719 SN-001 SN-001 是一种 STING 抑制剂,IC50 为 3.82 μM。
  10. GC67699 TLR8 agonist 5 TLR8 agonist 5 是有效的 TLR8 激动剂,对 HEK-Blue hTLR8 的 EC50 值为 20 nM。TLR8 agonist 5 激活免疫反应。
  11. GC52516 Erbstatin A tyrosine kinase inhibitor
  12. GC52514 Arachidonic Acid-d11 ethyl ester An internal standard for the quantification of arachidonic acid ethyl ester
  13. GC52505 Ganglioside GT1b (bovine) (sodium salt) A sphingolipid
  14. GC52501 2',3'-Dideoxyadenosine 5'-triphosphate (lithium salt) An inhibitor of reverse transcriptases and DNA polymerases
  15. GC52499 Abz-Ala-Pro-Glu-Glu-Ile-Met-Arg-Arg-Gln-EDDnp (trifluoroacetate salt) A sensitive substrate for neutrophil elastase
  16. GC52496 Sulfatide (bovine) (sodium salt) A mixture of isolated bovine sulfatides
  17. GC52492 Globotriaosylceramide (hydroxy) (porcine RBC) A sphingolipid
  18. GC52491 Globotriaosylceramide (non-hydroxy) (porcine RBC) A sphingolipid
  19. GC52489 Ceramide (hydroxy) (bovine spinal cord) A sphingolipid
  20. GC52487 Ganglioside GM4 (chicken egg) (ammonium salt) A sphingolipid
  21. GC52486 Ceramide Phosphoethanolamine (bovine) A sphingolipid
  22. GC52485 Ceramide (non-hydroxy) (bovine spinal cord) A sphingolipid
  23. GC52483 Fucosylated Ganglioside GM1 (porcine) (ammonium salt) A sphingolipid
  24. GC52476 Bax Inhibitor Peptide V5 (trifluoroacetate salt) A Bax inhibitor
  25. GC52475 Zanamivir-13C,15N2 (hydrate) An internal standard for the quantification of zanamivir
  26. GC52473 NVP-AAM077 An NMDA receptor antagonist
  27. GC52472 Inostamycin A (sodium salt) A bacterial metabolite with anticancer activity
  28. GC52471 7(S),10(S)-DiHOME An antibacterial hydroxy fatty acid
  29. GC52469 CL2A-SN-38 (dichloroacetic acid salt) An antibody-drug conjugate containing SN-38
  30. GC52468 Benanomicin B A microbial metabolite with antifungal, fungicidal, and antiviral activities
  31. GC52457 WRW4 (trifluoroacetate salt) A peptide antagonist of FPR2 and FPR3
  32. GC52455 Pixantrone-d8 (maleate) An internal standard for the quantification of pixantrone
  33. GC52446 2-Nonylquinolin-4(1H)-one-d4 An internal standard for the quantification of 2-nonylquinolin-4(1H)-one
  34. GC52445 2-nonyl-3-hydroxy-4-Quinolone-d4 An internal standard for the quantification of 2-nonyl-3-hydroxy-4-quinolone
  35. GC52442 (D)-PPA 1 (trifluoroacetate salt) An inhibitor of the PD-1-PD-L1 protein-protein interaction
  36. GC52436 TRAP-6 amide (trifluoroacetate salt) A peptide PAR1 agonist
  37. GC52434 Marbofloxacin-d8 (hydrochloride) An internal standard for the quantification of marbofloxacin
  38. GC52427 Apelin-12 (human, mouse, rat, bovine) (acetate) An endogenous agonist of the APJ receptor
  39. GC52426 Chemerin-9 (human) (acetate) A peptide agonist of CMKLR1 and CMKLR2
  40. GC52425 PD-1/PD-L1 Inhibitor 3 (trifluoroacetate salt) A PD-1/PD-L1 interaction inhibitor
  41. GC52424 Bradykinin Fragment (1-5) (trifluoroacetate salt) A metabolite of bradykinin
  42. GC52423 10Panx (trifluoroacetate salt) A peptide inhibitor of PANX1
  43. GC52421 (±)-10-hydroxy-12(Z)-Octadecenoic Acid-d5 An internal standard for the quantification of (±)-10-hydroxy-12(Z)-octadecenoic acid
  44. GC52419 MOG (35-55) (mouse, rat) (trifluoroacetate salt)

    An MOG antigen peptide

  45. GC52416 Histatin 5 (trifluoroacetate salt) An antimicrobial peptide
  46. GC52413 5-Aminosalicylic Acid-d7 An internal standard for the quantification of 5-aminosalicylic acid
  47. GC52412 TT-232 (trifluoroacetate salt) A synthetic peptide derivative of somatostatin
  48. GC52406 AMPR-22 (trifluoroacetate salt) An antimicrobial peptide
  49. GC52400 γ-Glu-Ala (trifluoroacetate salt) A dipeptide
  50. GC52395 Indolicidin (trifluoroacetate salt) An antimicrobial peptide
  51. GC52394 LC10 A lipidoid derivative of lithocholic acid

Items 151 to 200 of 3336 total

per page
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6

Set Descending Direction